Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population
Efficacy and safety of golimumab as add-on therapy to standard disease-modifying antirheumatic drugs : results of the GO-MORE study in the Polish population
pl
dc.type
JournalArticle
pl
dc.description.physical
493-499
pl
dc.description.volume
27
pl
dc.description.number
4
pl
dc.description.points
15
pl
dc.identifier.doi
10.17219/acem/68737
pl
dc.identifier.eissn
2451-2680
pl
dc.title.journal
Advances in Clinical and Experimental Medicine
pl
dc.language.container
eng
pl
dc.affiliation
Wydział Lekarski : Zakład Reumatologii i Balneologii
pl
dc.subtype
Article
pl
dc.rights.original
CC-BY-NC-ND; otwarte czasopismo; ostateczna wersja wydawcy; w momencie opublikowania; 0
Except where otherwise noted, this item's license is described as Key words: methotrexate, rheumatoid arthritis, golimumab, disease-modifying antirheumatic drugs